-
| ISIN | CNE1000047H6 |
|---|---|
| Exchange | SHE |
| Sector | Healthcare |
| Industry | Biotechnology |
| CurrencyCode | CNY |
| Beta | 0.46 |
|---|---|
| Market Cap | 4B |
| PE Ratio | None |
| Dividend Yield | 1.3% |
| Target Price | 17.89 |
Hvsen Biotechnology Co., Ltd. engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally. Its products include tylvalosin tartrate powders and raw materials; florfenicol, cefquinome sulfate, and tildipirosin injections; and florfenicol powder/WSP, tylosin tartrate soluble powder, and tywasin premix products. The company produces various veterinary drug products of raw materials and preparations, as well as traditional Chinese medicines extractives. Hvsen Biotechnology Co., Ltd. was founded in 2002 and is based in Wuhan, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300871.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025